Function of MEKK3 and its osmosensing scaffold protein
Function of MEKK3 and its osmosensing scaffold protein
批准号:
7889368
负责人:
GARY L. JOHNSON
金额:
$10.38万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-13 至 2010-07-31
关键词:
Adaptor Signaling ProteinAffectAgeAlanineAngiopoietin-1BackBehaviorBindingBinding ProteinsBlood capillariesBrainCCM1 geneCatalytic DomainCavernous MalformationCell NucleusCell physiologyCellsCerebrumComplexCytoplasmCytosolDiseaseDominant-Negative MutationEmployee StrikesEndothelial CellsFluorescenceFluorescence Recovery After PhotobleachingFluorescence Resonance Energy TransferGenesGoalsGrantImmunoblottingIndividualInheritedLeadLifeLipopolysaccharidesLocationMAP Kinase GeneMAPK14 geneMAPK7 geneMaintenanceMapsMeasuresMembraneMethodologyMigraineMultiprotein ComplexesMusMutateMutationNamesNatureNeuraxisNeurologicNuclearPTB DomainPathologyPathway interactionsPatientsPeptide HydrolasesPermeabilityPhosphorylationPhosphotransferasesPhotobleachingPopulationPreventionProteinsPublishingRecommendationRegulationRelative (related person)RepressionResearchResearch PersonnelRoleScaffolding ProteinSeizuresSerineSignal TransductionSmall Interfering RNASorbitolStimulusStressStrokeSymptomsTestingThrombinTight JunctionsTimeTubeUbiquitinUbiquitinationUnited StatesVascular Endothelial CellVascular Endothelial Growth FactorsWorkbasecapillarycellular imagingcytokinedisease-causing mutationhuman diseaseimmunocytochemistrymembermigrationmutantnovel therapeuticsnucleocytoplasmic transportoverexpressionprotein complexprotein degradationprotein functionpublic health relevancereceptorresearch studyresponsescaffoldsmall hairpin RNAubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): MEKK3 is a MAP3kinase that regulates the p38 and ERK5 MAPK pathways. A scaffolding protein was identified that binds MEKK3, named osmosensing scaffold for MEKK3 or OSM. OSM has been defined as a gene mutated in the human disease cerebral cavernous malformations (CCM). Familial CCM is a hereditary microvascular disorder that results in the formation of dilated, leaky capillaries in the central nervous system of affected individuals. Loci for CCM were mapped to three genes, Krit (ccm1), OSM (ccm2) and PDCD10 (ccm3). We have shown that OSM (CCM2), KRIT (CCM1) and PDCD10 (CCM3) are genetically in the same pathway and biochemically form a complex, indicating that they work in concert. CCM1, 2 and 3 appear to have no identifiable catalytic domains. CCM1 and CCM2 are scaffold-like proteins organizing a larger protein complex while CCM3 is predicted to have protein adaptor-like function. Our studies will define at a mechanistic level the function and spatio-temporal regulation of the CCM protein complex for the control of endothelial cell physiology. The hypothesis for this proposal is that the CCM protein complex is dynamic with spatio-temporal changes in composition and subcellular location. CCM1-CCM2-CCM3 complexes are localized both in the cytoplasm and in lamellipodia-like membrane protrusions. In addition, CCM2 rapidly transients in and out of the nucleus and functions as a nucleocytoplasmic shuttling protein. CCM1 can also be found in the nucleus and CCM2 overexpression redistributes CCM1 to the cytoplasm, indicating the CCM1-CCM2 interaction alters the localization of CCM1 in the cell (nuclear versus cytoplasmic), suggesting CCM2 may shuttle CCM1 out of the nucleus. CCM1 (KRIT) can target to endothelial cell tight junctions and regulate tight junction integrity. Thus, the dynamic regulation of CCM1 as part of the CCM1-CCM2-CCM3 complex appears required for the maintenance of microvascular integrity in the CNS. PUBLIC HEALTH RELEVANCE: CCM is a disease caused by mutation of genes encoding proteins that regulate the function of vascular endothelial cells. CCM affects approximately 0.5% of the population in the United States and is a major underlying pathology for hemorrhagic strike. The goal of this proposal is to understand the regulation and function of the CCM protein complex in vascular endothelial cells, which will lead to an understanding of the underlying pathology of CCM and provide potential new therapeutic strategies for cure and prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10251291
-
项目类别:
-
资助金额:$225.18万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9762097
-
项目类别:
-
资助金额:$226.6万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9453342
-
项目类别:
-
资助金额:$230.82万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10015261
-
项目类别:
-
资助金额:$225.92万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
The adaptive kinome in pancreatic cancer
-
批准号:8859584
-
项目类别:
-
资助金额:$57.37万
-
财政年份:2015
-
负责人:GARY L. JOHNSON
-
依托单位:
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
-
批准号:9120936
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2014
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8457042
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8273335
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8607578
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Molecular Therapeutics
-
批准号:8340206
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2011
-
负责人:GARY L. JOHNSON
-
依托单位:
Regulation of Sequential Protein Kinase Pathways
-
批准号:8038148
-
项目类别:
-
资助金额:$10.14万
-
财政年份:2010
-
负责人:GARY L. JOHNSON
-
依托单位:
Receptor Interaction with GTP-Regulatory Proteins
-
批准号:7867340
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2009
-
负责人:GARY L. JOHNSON
-
依托单位:
Defining Signal Network Plasticity
-
批准号:7498599
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2008
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7608096
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7378108
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
Inhibitor Screens for Five MAPK Kinase Kinases Important in Human Disease
-
批准号:7169344
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7203341
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2005
-
负责人:GARY L. JOHNSON
-
依托单位:
UNC Center for Nanosensing the Stressome (RMI)
-
批准号:6930731
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Efficacy of Coordinated Supportive Care in Gynecologic Oncology Patients
-
批准号:6981289
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Function of MEKK3 and its osmosensing scaffold protein
-
批准号:8123425
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2003
-
负责人:GARY L. JOHNSON
-
依托单位:
海外基金